JD Health International Inc. (OTCPK:JDHIF) Q4 2024 Earnings Call March 6, 2025 6:00 AM ET
Company Participants
Du Binglin – Head, Investor Relations
Jin Enlin – Executive Director and Chief Executive Officer
Deng Hui – Chief Financial Officer
Conference Call Participants
Lincoln Kong – Goldman Sachs
Kehan Meng – Haitong International
Xipeng Feng – CICC
Henry Liu – UBS
Operator
Good day, ladies and gentlemen. Thank you for standing by. Welcome to JD Health International, Inc. 2024 Annual Results Conference Call. [Operator Instructions] I will now turn the call over to Ms. Du Binglin, Head of Investor Relations. Please go ahead, Binglin.
Du Binglin
Thank you, operator. Good day, ladies and gentlemen. Welcome to our 2024 annual results conference call. Joining us today are JD Health Executive Director and CEO, Mr. Jin Enlin; and CFO, Ms. Deng Hui.
Before we start, we would like to remind you that today’s discussion may contain forward-looking statements, which involve a number of risks and uncertainties. Actual results and outcomes may differ materially from those mentioned in today’s announcement and this discussion. The company does not undertake any obligation to update this forward-looking information, except as required by law.
During today’s call, management will discuss certain non-IFRS financial measures for comparison purposes only. For a definition of non-IFRS financial measures and the reconciliation of IFRS to non-IFRS financial results, please refer to the annual results announcement for the year ended December 31, 2024, issued today.
For today’s call, management will read the prepared remarks in Chinese, and we will only be accepting questions in Chinese during the question-and-answer session. A third-party interpreter will provide simultaneous interpretation in English on a separate line for the duration of the call. Please note that English translation is for convenience purpose only. In the case of any discrepancy, management statements in the original language
